Skip to main content
Back to AI Intelligence Briefing
GovernanceAugust 21, 2026Source: American Hospital Association

FDA Seeks Feedback on Potential Regulatory Approaches for Generative AI-Enabled Medical Devices

The American Hospital Association reports that the FDA has opened a public comment process on its new discussion paper addressing regulatory options for **generative AI-based medical devices**. The document details considerations for clinical risk assessment and ongoing performance monitoring, signaling an evolving governance framework for AI tools used in patient care.

LOG Standards provides this short context and directs readers to the named publisher for the complete report. The source article remains the authoritative account of the underlying reporting.
Read Full Article

About LOG Standards

LOG Standards provides an independent accreditation signal for AI models used in healthcare, helping hospitals, care networks, and AI companies bring clinical AI readiness and governance into clearer conversations.

Our AI Intelligence Briefing tracks the latest developments in AI safety, AI in medicine, mental health AI, clinical AI governance, and regulatory policy — keeping healthcare stakeholders informed about the rapidly evolving AI landscape.